Long-Term Outcomes With Teduglutide From a Single Center.

Frances PuelloElizabeth WallJean HerlitzEdward S LozanoCarol SemradDejan Micic

Published in: JPEN. Journal of parenteral and enteral nutrition (2020)

In a real-world experience, teduglutide therapy results in rapid and sustained reductions in PS. Larger postmarketing studies will be required to reliably predict response to treatment and the factors associated with enteral autonomy.

Keyphrases

case control
bone marrow
cell therapy
loop mediated isothermal amplification
sensitive detection